Table 3.

Characteristics of the 10 Patients With Invasive Pulmonary Aspergillosis (IA) Who Had a Discordant Response (Failure According to European Organization for Research and Treatment of Cancer/Mycosis Study Group [EORTC/MSG] Definition, Success According to Aspergillus-Specific Galactomannan Index [GMI] Definition)

Patient	EORTC/MSG response	Time to GMI normalization, days	No. of GMI tests with negative resultsa	Lung infiltrates	Concomitant conditions	Survival after IA diagnosis	Survival after negative GMI test result
1	Failure, stable response	57	2	Stable	None	Alive	3 years
2	Failure, death	12	3	Worse	No IA at autopsy	15 days	3 days
3	Failure, death	20	18	Worse	PE, CMV disease	37 days	17 days
4	Failure, death	7	36	New infiltrates	Pseudomonas aeruginosa pneumonia and bacteremia	42 days	35 days
5	Failure, death	4	18	Worse	CMV colitis, VRE sepsis, cardiogenic shock	22 days	15 days
6	Failure, death	17	15	Not tested	P. aeruginosa pneumonia, VRE sepsis	33 days	16 days
7	Failure, death	9	30	Improved	PJP, CMV colitis	39 days	30 days
8	Failure, death	13	20	Worse	Klebsiella pneumoniae pneumonia	32 days	19 days
9	Failure, death	5	26	Worse	Accidental extubation, VRE sepsis	31 days	26 days
10	Failure, death	4	15	Not tested	Disseminated adenoviral infection, Clostridium difficile colitis,VRE sepsis	19 days	15 days

 Abbreviations: CMV, cytomegalovirus; PE, pulmonary embolism; PJP, Pneumocystis jirovecii pneumonia; VRE, vancomycin-resistant enterococci.

^aNumber of tests between first negative test result and death or last follow-up.